Phase II study of thalidomide plus dexamethasone induction followed by tandem melphalan-based autotransplantation and thalidomide-plus-prednisone maintenance for untreated multiple myeloma: a southwest oncology group trial (S0204).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples